NCT01578902View on ClinicalTrials.gov

Hypofractionated Accelerated Radiotherapy for Low Risk Localized Prostate Cancer

NACompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

April 30, 2008

Study Completion Date

April 30, 2013

Conditions
Prostate Cancer
Interventions
RADIATION

Stereotactic ablative body radiotherapy

35Gy/5 fractions/29 days

Trial Locations (1)

M4N 3M5

Sunnybrook Health Sciences Centre, Toronto

All Listed Sponsors
collaborator

Canadian Association of Radiation Oncology

INDUSTRY

lead

Sunnybrook Health Sciences Centre

OTHER

NCT01578902 - Hypofractionated Accelerated Radiotherapy for Low Risk Localized Prostate Cancer | Biotech Hunter | Biotech Hunter